Global Investors Learn About Region’s Cell & Gene Therapy and Connected Health Initiative at J.P. Morgan Conference in San Francisco

More than 9,000 attendees from across the globe, including industry leaders, emerging fast-growth companies, technology creators, and investors, are expected. 

Investor enthusiasm for cell and gene therapy is growing at a breathtaking pace

Investor enthusiasm for the cell and gene therapy space is robust and growing at a breathtaking pace. From R&D through M&A, the deal data – spanning only the most recent three years – is compelling.  Figures below, prepared by partner DealForma, illustrate the national trends.

Cell & Gene Therapy R&D Partnership Upfront Payments

Upfront payments for R&D partnerships in cell & gene therapy doubled from $15 million in 2017 to $30 million in 2018, and grew another 37% to $41 million in 2019.

The total value of […]